tm
Seeing Is Believing
tm
Seeing Is Believing
EIGR is currently covered by 4 analysts with an average price target of $13.79. This is a potential upside of $11.74 (572.68%) from yesterday's end of day stock price of $2.05.
Eiger Biopharmaceuticals's activity chart (see below) currently has 36 price targets and 34 ratings on display. The stock rating distribution of EIGR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 22.96% with an average time for these price targets to be met of 94.67 days.
Highest price target for EIGR is $3, Lowest price target is $3, average price target is $13.79.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023. First documented stock forecast 24-Mar-2016.
Currently out of the existing stock ratings of EIGR, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3
$0.89 (42.18%)
4
7 months 21 days ago
2/5 (40%)
$2.15 (252.94%)
264
Buy
3
$0.89 (42.18%)
3
9 months 20 days ago
2/3 (66.67%)
$2.3 (328.57%)
294
Buy
3
$0.89 (42.18%)
3
9 months 20 days ago
2/2 (100%)
$2.3 (328.57%)
294
Buy
1 years 4 months 7 days ago
0/3 (0%)
$35.04 (351.81%)
Buy
22
$19.89 (942.65%)
34
3 years 4 months 25 days ago
0/5 (0%)
$13.25 (151.43%)
What is EIGR (Eiger Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on EIGR (Eiger Biopharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on EIGR (Eiger Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most bullish on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most reserved on EIGR (Eiger Biopharmaceuticals)?
